Analyst Upgrades – Medifast (NYSE:MED) Stock Gets Upgraded By Sidoti from Neutral to Buy

Analyst Ratings For Medifast (NYSE:MED)

Story continues below

Today, Medifast (NYSE:MED) stock received an upgrade by Sidoti from Neutral to Buy.

Some recent analyst ratings include

  • 3/7/2018-Sidoti Upgrade from a “Neutral ” rating to a ” Buy” rating.

Dividend information for Medifast (NYSE:MED)

Medifast (NYSE:MED) pays an annual dividend of $1.92 with a yield of 2.12% and an average dividend growth of 0.00% based on a 3 Year Average..

Dividend History for Medifast (NYSE:MED)

  • On 12/7/2017 Medifast announced a quarterly dividend of $0.48 2.69% with an ex dividend date of 12/21/2017 which will be payable on 2/8/2018.
  • On 9/7/2017 Medifast announced a quarterly dividend of $0.32 2.31% with an ex dividend date of 9/21/2017 which will be payable on 11/9/2017.
  • On 6/7/2017 Medifast announced a Quarterly dividend of $0.32 3.1% with an ex dividend date of 6/21/2017 which will be payable on 8/9/2017.
  • On 3/8/2017 Medifast announced a quarterly dividend of $0.32 2.92% with an ex dividend date of 3/21/2017 which will be payable on 5/9/2017.
  • On 12/9/2016 Medifast announced a quarterly dividend of $0.32 3.13% with an ex dividend date of 12/21/2016 which will be payable on 2/9/2017.
  • On 9/9/2016 Medifast announced a quarterly dividend of $0.25 2.75% with an ex dividend date of 9/21/2016 which will be payable on 11/10/2016.
  • On 6/16/2016 Medifast announced a quarterly dividend of $0.25 3.04% with an ex dividend date of 6/23/2016 which will be payable on 8/10/2016.

Recent Insider Trading Activity For Medifast (NYSE:MED)
Medifast (NYSE:MED) has insider ownership of 5.40% and institutional ownership of 88.14%.

  • On 12/1/2017 Glenn W Welling, Director, sold 275,000 with an average share price of $64.60 per share and the total transaction amounting to $17,765,000.00.
  • On 11/13/2017 Glenn W Welling, Director, sold 250,000 with an average share price of $65.00 per share and the total transaction amounting to $16,250,000.00.
  • On 9/21/2017 Ralph Rushton, Director, sold 25,000 with an average share price of $0.18 per share and the total transaction amounting to $4,500.00.
  • On 9/6/2017 Jeremy John Martin, Director, sold 131,500 with an average share price of $0.18 per share and the total transaction amounting to $23,670.00.
  • On 7/7/2017 Simon T.P. Ridgway, Insider, bought 1,500 with an average share price of $0.15 per share and the total transaction amounting to $225.00.
  • On 7/5/2017 Simon T.P. Ridgway, Insider, bought 29,000 with an average share price of $0.15 per share and the total transaction amounting to $4,350.00.
  • On 3/14/2017 Glenn W Welling, Director, bought 17,084 with an average share price of $41.33 per share and the total transaction amounting to $706,081.72.

Recent Trading Activity for Medifast (NYSE:MED)
Shares of Medifast closed the previous trading session at 91.48 up +24.28 36.13% with 79.80999755859375 shares trading hands.

An ad to help with our costs